Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine vs Cyclophosphamide Conditioning in Aplastic Anemia
NCT01145976Phase 3Unknown
- Sponsor
- Japan Adult Leukemia Study Group
- Start
- Mar 2010
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fludarabine in aplastic anemia (2 arms), sponsored by Japan Adult Leukemia Study Group. Primary endpoint: Regimen-related toxicities at 7 years. Status: unknown.
02
Drugs
fludarabine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT01145976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01145976.